Fine Fettle has transformed its nine Connecticut cannabis dispensaries into hybrid facilities, enabling each to accommodate both registered medical marijuana patients and adult-use buyers. This shift, completed under a recent state law change, expands access to medical services in regions previously limited to recreational sales. Company leaders emphasize that the move preserves specialized care for patients while broadening the program's reach across the state.
Expanding Access Through Legal Reforms
Connecticut's cannabis landscape evolved with last year's Responsible Expansion of the RERACA Act, which permitted recreational dispensaries to adopt hybrid models starting October 1. The law also introduced flexibility for pharmacists to handle patient verifications and consultations remotely, reducing the need for constant on-site presence. Fine Fettle seized this opportunity to convert five locations—Manchester, Norwalk, Old Saybrook, Waterbury, and West Hartford—from recreational-only operations, while four others in Bristol, Newington, Stamford, and Willimantic already functioned as hybrids.
Operational Upgrades for Medical Patients
Hybrid sites now feature dedicated medical registers and licensed pharmacist availability, either in person for at least eight contiguous hours weekly or remotely during all operating hours, as required by state regulations. Patients gain entry to stronger medical-only products, tax-exempt pricing, and private consultation spaces for discussing needs. Fine Fettle prepared over six months, enduring 15 state inspections, revising procedures, installing new technology, and adjusting staffing to ensure compliance and coverage.
Patient Benefits and Broader Implications
Medical patients, especially in underserved areas, now avoid long travels for care, with promotions like discounts on first three purchases for newcomers. Chief Operating Officer Benjamin Zachs described the effort as promoting efficiency and equity, sustaining Connecticut's medical program amid recreational market growth. "Patients shouldn’t have to travel far for care or be stuck with limited options," Zachs said, crediting lawmakers and regulators. This expansion reflects a national trend where states balance adult-use markets with protected medical access, potentially strengthening program stability and patient trust.
